Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03207880 · ClinicalTrials.gov registry record · NA

Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services

A NA study, sponsored by Gynuity Health Projects.

Completed
Registry status
NA
Development phase
165
Enrollment target

NCT03207880 is a NA study that has completed, run by Gynuity Health Projects. The registered enrollment target is 165 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03207880, a NA study, has completed, sponsored by Gynuity Health Projects.

COMPLETED
Registry status
NA
Development phase
165 participants
Enrollment target

Study Summary

Serial use of urine multi-level pregnancy tests (MLPTs) has been shown to be a reliable and efficient strategy for excluding ongoing pregnancy after medical abortion at ≤ 63 days of gestation. This pilot project will assess whether MLPTs can enhance the quality of remote medical abortion services through enabling women to reliably ascertain their abortion outcomes at home sooner than would otherwise have been the case. safe2choose provides remote medical abortion services through the Internet (information, counselling and access to abortion pills) in a growing number of countries worldwide. safe2choose will collaborate with Gynuity Health Projects to pilot the utility of MLPTs for home follow-up as part of its remote medical abortion services. As safe2choose does not have a physical office, the location of the sponsor's office is listed in this entry as the study location. Women from the United States are NOT eligible to enroll.

Interventions

  • DEVICE Multi-level pregnancy test

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2017-11-01
Est. Completion 2018-08-10
Phase NA

Sponsor

Gynuity Health Projects

29 total trials

What the Registry Record Tells You About NCT03207880

The ClinicalTrials.gov registry entry for NCT03207880 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Multi-level pregnancy test is the first listed.

NCT03207880 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03207880 about?

NCT03207880 is a clinical study titled "Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services". Serial use of urine multi-level pregnancy tests (MLPTs) has been shown to be a reliable and efficient strategy for excluding ongoing pregnancy after medical abortion at ≤ 63 days of gestation. This pilot project will assess whether MLPTs can enhance the quality of remote medical abortion services th...

What is the current status of trial NCT03207880?

This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2017-11-01. Estimated completion is 2018-08-10.

What interventions are being tested in trial NCT03207880?

The interventions under investigation include: Multi-level pregnancy test (DEVICE).

Who is sponsoring clinical trial NCT03207880?

This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.